IDiyas

For the Inventor, By the Inventor

Framingham, MA, United States of America

Manish Tandon

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 6.3

ph-index = 5

Forward Citations = 85(Granted Patents)


Company Filing History:

goldMedal24 out of 104 
 
Arqule, Inc.
 patents

Years Active: 2009-2021

Loading Chart...
Loading Chart...
24 patents (USPTO):
1. 11020398 - Amino-pyrrolopyrimidinone compounds and methods of use thereof (2021-06-01),
2. 8962619 - Substituted imidazopyridinyl-aminopyridine compounds (2015-02-24),
3. 8906928 - Substituted pyrazolo-pyrrolo-pyridine-dione compounds (2014-12-09),
4. 8815854 - Substituted imidazopyridinyl compounds (2014-08-26),
5. 8614228 - Quinone prodrug compositions and methods of use (2013-12-24),
6. 8609688 - Substituted imidazopyridinyl-aminopyridine compounds (2013-12-17),
7. 8580803 - Substituted pyrrolo-aminopyrimidine compounds (2013-11-12),
8. 8541407 - Substituted benzo-pyrido-triazolo-diazepine compounds (2013-09-24),
9. 8501770 - Substituted imidazopyridinyl-aminopyridine compounds (2013-08-06),
10. 8497276 - Substituted indolo-piperidine compounds (2013-07-30),
11. 8410144 - Substituted indolo-pyridinone compounds (2013-04-02),
12. 8357694 - Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds (2013-01-22),
13. 8349827 - Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds (2013-01-08),
14. 8343983 - Substituted pyrazolo-pyrimidine compounds (2013-01-01),
15. 8273754 - Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds (2012-09-25),

Title: **Manish Tandon: Innovator in Pharmaceutical Chemistry**

Introduction

Manish Tandon is a highly accomplished inventor located in Framingham, Massachusetts. With a strong focus on pharmaceutical chemistry, Tandon has been instrumental in developing compounds that have significant implications in treating various diseases. With a remarkable portfolio of 24 patents, his contributions to the field are both innovative and impactful.

Latest Patents

Among his latest inventions, Tandon has created amino-pyrrolopyrimidinone compounds. This particular patent relates to a compound represented by a specific formula that modulates the activity of BTK (Bruton’s tyrosine kinase), which is crucial in treating various diseases where BTK plays a role. Additionally, he has worked on substituted imidazopyridinyl-aminopyridine compounds. This patent focuses on methods for synthesizing these compounds, as well as their pharmaceutical compositions, aimed at treating cell proliferative disorders, such as cancer.

Career Highlights

Manish Tandon currently works with Arqule, Inc., a prominent company dedicated to advancing innovative medicines for patients. His role at Arqule has allowed him to contribute to groundbreaking research and refine his skills in pharmacology and medicinal chemistry, leading to numerous successful patent applications.

Collaborations

Throughout his career, Tandon has had the opportunity to collaborate with talented professionals in the industry. Notable coworkers include Mark Anthony Ashwell and Jean-Marc Lapierre, with whom he has shared valuable insights and expertise, enhancing his work and fostering a collaborative environment.

Conclusion

Manish Tandon’s significant contributions through his patents demonstrate his commitment to innovation in pharmaceutical research. His work is not only advancing the scientific community but also has the potential to improve patient care and treatment outcomes in the healthcare sector. As he continues his journey at Arqule, Tandon's future endeavors are eagerly anticipated by peers and professionals alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…